Shaheen Alanee

Academic / Other · 1 registered clinical trial — 1 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy High Risk Superficial Upper Urinary Tract Transitional Cell Carcinoma, Endoscopic Surgical Procedure, Transitional Epithelial Cells	Phase 2	2017-11-30